Genetic Mapping for Oncology Cancer Test sale cost 3980 AED
Liquid Biopsy CfDNA EGFR Test sale cost 4510 AED Liquid Biopsy CfDNA EGFR Test Cost 5,010 د.إ Original price was: 5,010 د.إ.4,510 د.إCurrent price is: 4,510 د.إ.
Myeloproliferative Neoplasia with Eosinophilia Test sale cost 3860 AED Myeloproliferative Neoplasia with Eosinophilia Test Cost 4,290 د.إ Original price was: 4,290 د.إ.3,860 د.إCurrent price is: 3,860 د.إ.
Sale!

Genetic Mapping for Oncology Cancer Test Cost

Original price was: 4,420 د.إ.Current price is: 3,980 د.إ.

-10%

Genetic mapping for oncology cancer tests is a cutting-edge diagnostic approach used to identify specific genes that are linked to the development and progression of cancer. By analyzing an individual’s genetic makeup, this test can pinpoint genetic mutations or alterations that may increase the risk of certain types of cancer. Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, the test offers valuable insights into one’s genetic predisposition to cancer, enabling personalized and more effective treatment strategies.

The cost of the genetic mapping for oncology cancer test at DNA Labs UAE is 3980 AED. This investment in personal health allows individuals to take proactive steps in managing their cancer risk. The information gleaned from the test can guide healthcare providers in recommending targeted surveillance, preventive measures, or therapeutic interventions tailored to the genetic profile of the patient. This personalized approach not only enhances the efficacy of treatment plans but also improves the overall quality of life for those at risk of or battling cancer.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Genetic Mapping for Oncology Cancer Test

Test Name: GENETIC MAPPING FOR ONCOLOGY CANCER Test

Components: Price – 3980.0 AED

Sample Condition: Submit 3 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genome Mapping Consent Form (Form 26) is mandatory.

Report Delivery: Sample Daily by 9 am; Report 8 weeks

Method: SNP Genotyping using Microarray

Test type: Cancer

Doctor: Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled Genome Mapping Consent Form (Form 26) is mandatory.

Introduction

Genetic mapping for oncology or cancer testing involves analyzing a person’s DNA to identify specific genetic mutations or variations that may increase their risk of developing cancer or influence their response to cancer treatment. This type of testing is often used to guide personalized treatment decisions and to assess an individual’s risk of developing certain types of cancer.

Methods Used for Genetic Mapping in Oncology

  1. Next-generation sequencing (NGS): This technology allows for the rapid and cost-effective sequencing of large sections of the genome. NGS can be used to identify mutations in specific cancer-related genes, such as BRCA1 and BRCA2, which are associated with an increased risk of breast and ovarian cancer.
  2. Polymerase chain reaction (PCR): PCR is a technique used to amplify specific DNA sequences. It can be used to identify specific genetic mutations or variations in cancer-related genes, such as KRAS or EGFR, which can help guide targeted therapy decisions.
  3. Fluorescence in situ hybridization (FISH): FISH is a technique that uses fluorescent probes to visualize specific DNA sequences within cells. It can be used to detect genetic abnormalities, such as gene amplifications or translocations, which are common in certain types of cancer.
  4. Microarray analysis: This technique involves the use of DNA microarrays to simultaneously analyze thousands of genetic markers. It can be used to identify chromosomal abnormalities or gene expression patterns associated with cancer.

Benefits of Genetic Mapping for Oncology

Genetic mapping for oncology can provide valuable information for both cancer prevention and treatment. It can help identify individuals who may benefit from increased cancer screening or preventive measures, such as prophylactic surgery or targeted therapies. Additionally, it can guide treatment decisions by identifying specific genetic mutations or variations that may influence a person’s response to certain cancer drugs.

It’s important to note that genetic mapping for oncology is typically done in conjunction with other clinical and pathological assessments to provide a comprehensive understanding of an individual’s cancer risk or treatment options. It is usually performed by specialized laboratories or genetic counselors who can interpret the results and provide appropriate recommendations based on the findings.

Test Name GENETIC MAPPING FOR ONCOLOGY CANCER Test
Components
Price 3980.0 AED
Sample Condition Submit 3 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube.Ship refrigerated. DO NOT FREEZE.Duly filled Genome Mapping Consent Form (Form 26) is mandatory.
Report Delivery Sample Daily by 9 am; Report 8 weeks
Method SNP Genotyping using Microarray
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Genome Mapping Consent Form (Form 26) is mandatory.
Test Details

Genetic mapping for oncology or cancer testing involves analyzing a person’s DNA to identify specific genetic mutations or variations that may increase their risk of developing cancer or influence their response to cancer treatment. This type of testing is often used to guide personalized treatment decisions and to assess an individual’s risk of developing certain types of cancer.

There are several different methods used for genetic mapping in oncology, including:

1. Next-generation sequencing (NGS): This technology allows for the rapid and cost-effective sequencing of large sections of the genome. NGS can be used to identify mutations in specific cancer-related genes, such as BRCA1 and BRCA2, which are associated with an increased risk of breast and ovarian cancer.

2. Polymerase chain reaction (PCR): PCR is a technique used to amplify specific DNA sequences. It can be used to identify specific genetic mutations or variations in cancer-related genes, such as KRAS or EGFR, which can help guide targeted therapy decisions.

3. Fluorescence in situ hybridization (FISH): FISH is a technique that uses fluorescent probes to visualize specific DNA sequences within cells. It can be used to detect genetic abnormalities, such as gene amplifications or translocations, which are common in certain types of cancer.

4. Microarray analysis: This technique involves the use of DNA microarrays to simultaneously analyze thousands of genetic markers. It can be used to identify chromosomal abnormalities or gene expression patterns associated with cancer.

Genetic mapping for oncology can provide valuable information for both cancer prevention and treatment. It can help identify individuals who may benefit from increased cancer screening or preventive measures, such as prophylactic surgery or targeted therapies. Additionally, it can guide treatment decisions by identifying specific genetic mutations or variations that may influence a person’s response to certain cancer drugs.

It’s important to note that genetic mapping for oncology is typically done in conjunction with other clinical and pathological assessments to provide a comprehensive understanding of an individual’s cancer risk or treatment options. It is usually performed by specialized laboratories or genetic counselors who can interpret the results and provide appropriate recommendations based on the findings.

SKU: TEST-4669 Category:

Related products